Achieving end-to-end success in the clinic: Pfizer’s learnings on R&D productivity

Over the past decade, Pfizer has focused efforts to improve its research and development (R&D) productivity. By the end of 2020, Pfizer had achieved an industry-leading clinical success rate of 21%, a tenfold increase from 2% in 2010 and well above the industry benchmark of ∼11%. The company had...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernando, Kathy, Menon, Sandeep, Jansen, Kathrin, Naik, Prakash, Nucci, Gianluca, Roberts, John, Wu, Shuang Sarah, Dolsten, Mikael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2022
Materias:
Feature
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719639/
https://www.ncbi.nlm.nih.gov/pubmed/34922020
http://dx.doi.org/10.1016/j.drudis.2021.12.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719639/
https://www.ncbi.nlm.nih.gov/pubmed/34922020
http://dx.doi.org/10.1016/j.drudis.2021.12.010

Ejemplares similares